Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily

PHASE2CompletedINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

June 28, 2010

Primary Completion Date

October 6, 2011

Study Completion Date

October 6, 2011

Conditions
Asthma
Interventions
DRUG

Fluticasone Propionate 100mcg via ACCUHALER/DISKUS

Fluticasone propionate 100mcg twice daily via ACCUHALER/DISKUS

DRUG

GSK2190915 100mg

GSK2190915 100mg (1 x 100mg) once daily in the morning

DRUG

GSK2190915 10mg

GSK2190915 10mg (1 x 10mg) once daily in the morning

DRUG

GSK2190915 300mg

GSK2190915 300mg (1 x 100mg, 1 x 200mg tablets) once daily in the morning

DRUG

GSK2190915 30mg

GSK2190915 30mg (1 x 30mg) once daily in the morning

DRUG

Montelukast 10mg

Montelukast 10mg (1 x 10mg capsule) once daily in the evening

DRUG

Placebo GSK2190915 one tablet

Placebo tablet, one tablet once daily in the morning

DRUG

Placebo montelukast

Placebo capsule once daily in the evening

DRUG

Placebo fluticasone propionate via ACCUHALER/DISKUS

Inhaled placebo twice daily via ACCUHALER/DISKUS

DRUG

Placebo GSK2190915 two tablets

Placebo tablet, two tablets once daily in the morning

Trial Locations (84)

1000

GSK Investigational Site, Sofia

1202

GSK Investigational Site, Sofia

1407

GSK Investigational Site, Sofia

1431

GSK Investigational Site, Sofia

4003

GSK Investigational Site, Plovdiv

5800

GSK Investigational Site, Pleven

6000

GSK Investigational Site, Stara Zagora

7000

GSK Investigational Site, Rousse

9010

GSK Investigational Site, Varna

27607

GSK Investigational Site, Raleigh

29118

GSK Investigational Site, Orangeburg

32308

GSK Investigational Site, Tallahassee

35209

GSK Investigational Site, Birmingham

42301

GSK Investigational Site, Owensboro

44718

GSK Investigational Site, Canton

48197

GSK Investigational Site, Ypsilanti

49006

GSK Investigational Site, Dnipropetrovsk

49027

GSK Investigational Site, Dnipropetrovsk

49051

GSK Investigational Site, Dnipropetrovsk

55402

GSK Investigational Site, Minneapolis

61002

GSK Investigational Site, Kharkiv

61037

GSK Investigational Site, Kharkiv

61124

GSK Investigational Site, Kharkiv

63141

GSK Investigational Site, St Louis

65114

GSK Investigational Site, Odesa

65203

GSK Investigational Site, Columbia

65401

GSK Investigational Site, Rolla

69035

GSK Investigational Site, Zaporizhia

70006

GSK Investigational Site, Metairie

73103

GSK Investigational Site, Oklahoma City

76018

GSK Investigational Site, Ivano-Frankivsk

76712

GSK Investigational Site, Waco

78229

GSK Investigational Site, San Antonio

83099

GSK Investigational Site, Donetsk

92123

GSK Investigational Site, San Diego

92647

GSK Investigational Site, Huntington Beach

92663

GSK Investigational Site, Newport Beach

95043

GSK Investigational Site, Simferopol

97504

GSK Investigational Site, Medford

98225

GSK Investigational Site, Bellingham

98603

GSK Investigational Site, Yalta

300310

GSK Investigational Site, Timișoara

330084

GSK Investigational Site, Deva

400217

GSK Investigational Site, Cluj-Napoca

400371

GSK Investigational Site, Cluj-Napoca

500112

GSK Investigational Site, Brasov

04401

GSK Investigational Site, Bangor

07712

GSK Investigational Site, Ocean City

292-0805

GSK Investigational Site, Chiba

819-0006

GSK Investigational Site, Fukuoka

819-1102

GSK Investigational Site, Fukuoka

062-0034

GSK Investigational Site, Hokkaido

064-0801

GSK Investigational Site, Hokkaido

319-1113

GSK Investigational Site, Ibaraki

210-0852

GSK Investigational Site, Kanagawa

530-0001

GSK Investigational Site, Osaka

565-0853

GSK Investigational Site, Osaka

343-0851

GSK Investigational Site, Saitama

102-0083

GSK Investigational Site, Tokyo

103-0027

GSK Investigational Site, Tokyo

103-0028

GSK Investigational Site, Tokyo

130-8587

GSK Investigational Site, Tokyo

153-0051

GSK Investigational Site, Tokyo

154-0024

GSK Investigational Site, Tokyo

158-0097

GSK Investigational Site, Tokyo

171-0014

GSK Investigational Site, Tokyo

190-0013

GSK Investigational Site, Tokyo

15-084

GSK Investigational Site, Bialystok

40-018

GSK Investigational Site, Katowice

31-024

GSK Investigational Site, Krakow

32-590

GSK Investigational Site, Libiąż

93-329

GSK Investigational Site, Lodz

60-693

GSK Investigational Site, Poznan

33-100

GSK Investigational Site, Tarnów

020125

GSK Investigational Site, Bucharest

022102

GSK Investigational Site, Bucharest

050159

GSK Investigational Site, Bucharest

03680

GSK Investigational Site, Kiev

GSK Investigational Site, Kyiv

02232

GSK Investigational Site, Kyiv

03115

GSK Investigational Site, Kyiv

04107

GSK Investigational Site, Kyiv

04201

GSK Investigational Site, Kyiv

Unknown

GSK Investigational Site, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY